Standardized SEC financial data for BIOLASE, INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000811240 · Dental Equipment & Supplies.
Ratios for fiscal year 2023, standardized from SEC filings.
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2023 |
|---|---|---|---|---|---|---|
| Revenue | $37.8M | $22.8M | $39.2M | $48.5M | — | $49.2M |
| Cost of revenue | $23.5M | $16.6M | $22.7M | $32.6M | — | $32.4M |
| Gross profit | $14.3M | $6.2M | $16.5M | $15.9M |
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.4M | $6.1M | $17.9M | $30.2M | $4.2M | $6.6M |
| Inventory | $12.2M | $11.0M | $11.2M | $12.9M | $15.9M | $11.4M |
| Total current assets | $33.3M | $27.0M | $35.1M | $49.4M |
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.1M | -$12.7M | -$12.8M | -$16.7M | -$26.8M | -$14.1M |
| Capital expenditures | $558K | $207K | $96K | $707K | $3.7M | $1.3M |
| Free cash flow | -$14.7M | -$13.0M | -$12.9M | -$17.4M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000811240/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000811240/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| — |
| $16.7M |
| R&D expense | $4.8M | $3.7M | $6.0M | $7.3M | — | $6.0M |
| SG&A expense | $14.4M | $11.2M | $15.3M | $21.7M | — | $18.4M |
| Operating income | -$15.6M | -$18.5M | -$16.4M | -$25.3M | — | -$17.9M |
| EBITDA | -$14.6M | -$18.0M | -$16.0M | -$24.8M | — | -$15.1M |
| Interest expense | $1.8M | $1.9M | $1.8M | $1.5M | — | $1.9M |
| Pretax income | -$17.9M | -$16.7M | -$16.1M | -$28.5M | — | -$20.6M |
| Income tax | $44K | $128K | $65K | $109K | — | $31K |
| Net income | -$17.9M | -$34.2M | -$16.7M | -$28.9M | — | -$37.6M |
| EPS (diluted) | $-0.77 | $-13.99 | $-283.12 | $-418.13 | — | $-29.44 |
Standardized from BIOLASE, INC's SEC filings — per-share figures split-adjusted. Full history via the API.
| $29.0M |
| $24.9M |
| Property, plant & equipment | $2.0M | $1.2M | $782K | $1.1M | $4.3M | $5.5M |
| Goodwill | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M |
| Total assets | $38.5M | $31.8M | $41.0M | $55.3M | $38.2M | $35.1M |
| Total current liabilities | $16.0M | $25.8M | $11.2M | $13.8M | $17.8M | $19.7M |
| Long-term debt | $10.8M | $13.5M | $16.2M | $13.6M | $13.8M | $14.0M |
| Total debt | $10.8M | $26.9M | $16.2M | $13.6M | $14.5M | $16.3M |
| Total liabilities | $27.4M | $31.5M | $31.0M | $30.1M | $33.3M | $35.3M |
| Retained earnings | -$216.7M | -$234.5M | -$251.4M | -$267.5M | -$296.2M | -$316.8M |
| Total equity | $11.1M | $377K | $10.0M | $25.2M | $4.9M | -$247K |
| -$30.5M |
| -$15.4M |
| Investing cash flow | -$522K | -$207K | -$96K | -$707K | -$3.7M | -$1.1M |
| Financing cash flow | $11.2M | $10.7M | $24.3M | $30.0M | $4.6M | $17.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |